100 related articles for article (PubMed ID: 28475006)
21. MiR-613 suppresses retinoblastoma cell proliferation, invasion, and tumor formation by targeting E2F5.
Zhang Y; Zhu X; Zhu X; Wu Y; Liu Y; Yao B; Huang Z
Tumour Biol; 2017 Mar; 39(3):1010428317691674. PubMed ID: 28351331
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-1225-5p inhibits proliferation and metastasis of gastric carcinoma through repressing insulin receptor substrate-1 and activation of β-catenin signaling.
Zheng H; Zhang F; Lin X; Huang C; Zhang Y; Li Y; Lin J; Chen W; Lin X
Oncotarget; 2016 Jan; 7(4):4647-63. PubMed ID: 26684358
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-365 inhibits growth, invasion and metastasis of malignant melanoma by targeting NRP1 expression.
Bai J; Zhang Z; Li X; Liu H
Cancer Biomark; 2015; 15(5):599-608. PubMed ID: 26406949
[TBL] [Abstract][Full Text] [Related]
24. miR-137 inhibits melanoma cell proliferation through downregulation of GLO1.
Lv N; Hao S; Luo C; Abukiwan A; Hao Y; Gai F; Huang W; Huang L; Xiao X; Eichmüller SB; He D
Sci China Life Sci; 2018 May; 61(5):541-549. PubMed ID: 29307109
[TBL] [Abstract][Full Text] [Related]
25. INPP4B is upregulated and functions as an oncogenic driver through SGK3 in a subset of melanomas.
Chi MN; Guo ST; Wilmott JS; Guo XY; Yan XG; Wang CY; Liu XY; Jin L; Tseng HY; Liu T; Croft A; Hondermarck H; Scolyer RA; Jiang CC; Zhang XD
Oncotarget; 2015 Nov; 6(37):39891-907. PubMed ID: 26573229
[TBL] [Abstract][Full Text] [Related]
26. MiR-135 post-transcriptionally regulates FOXO1 expression and promotes cell proliferation in human malignant melanoma cells.
Ren JW; Li ZJ; Tu C
Int J Clin Exp Pathol; 2015; 8(6):6356-66. PubMed ID: 26261511
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-605 functions as a tumor suppressor by targeting INPP4B in melanoma.
Chen L; Cao Y; Rong D; Wang Y; Cao Y
Oncol Rep; 2017 Aug; 38(2):1276-1286. PubMed ID: 28656250
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-340 promotes the tumor growth of human gastric cancer by inhibiting cyclin G2.
Yin G; Zhou H; Xue Y; Yao B; Zhao W
Oncol Rep; 2016 Aug; 36(2):1111-8. PubMed ID: 27374211
[TBL] [Abstract][Full Text] [Related]
29. miR-194 is a negative regulator of GEF-H1 pathway in melanoma.
Guo B; Hui Q; Zhang Y; Chang P; Tao K
Oncol Rep; 2016 Oct; 36(4):2412-20. PubMed ID: 27573550
[TBL] [Abstract][Full Text] [Related]
30. MiR-26b inhibits melanoma cell proliferation and enhances apoptosis by suppressing TRAF5-mediated MAPK activation.
Li M; Long C; Yang G; Luo Y; Du H
Biochem Biophys Res Commun; 2016 Mar; 471(3):361-7. PubMed ID: 26872428
[TBL] [Abstract][Full Text] [Related]
31. Emerging role of microRNA-27a in human malignant glioma cell survival via targeting of prohibitin.
Chen W; Qi J; Bao G; Wang T; Du CW; Wang MD
Mol Med Rep; 2015 Jul; 12(1):1515-23. PubMed ID: 25777779
[TBL] [Abstract][Full Text] [Related]
32. miR-503 inhibits cell proliferation and induces apoptosis in colorectal cancer cells by targeting E2F3.
Chang SW; Yue J; Wang BC; Zhang XL
Int J Clin Exp Pathol; 2015; 8(10):12853-60. PubMed ID: 26722476
[TBL] [Abstract][Full Text] [Related]
33. MiR-145 suppressed human retinoblastoma cell proliferation and invasion by targeting ADAM19.
Sun Z; Zhang A; Jiang T; Du Z; Che C; Wang F
Int J Clin Exp Pathol; 2015; 8(11):14521-7. PubMed ID: 26823772
[TBL] [Abstract][Full Text] [Related]
34. IL-10Rα expression is post-transcriptionally regulated by miR-15a, miR-185, and miR-211 in melanoma.
Venza I; Visalli M; Beninati C; Benfatto S; Teti D; Venza M
BMC Med Genomics; 2015 Dec; 8():81. PubMed ID: 26631117
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-409-5p is upregulated in breast cancer and its downregulation inhibits cancer development through downstream target of RSU1.
Yu H; Xing H; Han W; Wang Y; Qi T; Song C; Xu Z; Li H; Huang Y
Tumour Biol; 2017 May; 39(5):1010428317701647. PubMed ID: 28459205
[TBL] [Abstract][Full Text] [Related]
36. MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma.
Zehavi L; Schayek H; Jacob-Hirsch J; Sidi Y; Leibowitz-Amit R; Avni D
Mol Cancer; 2015 Mar; 14():68. PubMed ID: 25889255
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma.
Satzger I; Mattern A; Kuettler U; Weinspach D; Voelker B; Kapp A; Gutzmer R
Int J Cancer; 2010 Jun; 126(11):2553-62. PubMed ID: 19830692
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of microRNA-211 is involved in expression of preferentially expressed antigen of melanoma in melanoma cells.
Sakurai E; Maesawa C; Shibazaki M; Yasuhira S; Oikawa H; Sato M; Tsunoda K; Ishikawa Y; Watanabe A; Takahashi K; Akasaka T; Masuda T
Int J Oncol; 2011 Sep; 39(3):665-72. PubMed ID: 21687938
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-124a is epigenetically regulated and acts as a tumor suppressor by controlling multiple targets in uveal melanoma.
Chen X; He D; Dong XD; Dong F; Wang J; Wang L; Tang J; Hu DN; Yan D; Tu L
Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):2248-56. PubMed ID: 23404119
[TBL] [Abstract][Full Text] [Related]
40. miR-137 suppresses tumor growth of malignant melanoma by targeting aurora kinase A.
Chang X; Zhang H; Lian S; Zhu W
Biochem Biophys Res Commun; 2016 Jul; 475(3):251-6. PubMed ID: 27233613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
